The nanoscale in pulmonary delivery. Part 2: formulation platforms (Q36985898)

17 August 2017

1 reference

title

The nanoscale in pulmonary delivery. Part 2: formulation platforms (English)

1 reference

17 August 2017

2

Daniela Traini

1 reference

17 August 2017

Philippe Ga Rogueda

1

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 November 2007

1 reference

Expert Opinion on Drug Delivery

17 August 2017

published in

1 reference

17 August 2017

volume

4

1 reference

17 August 2017

issue

6

1 reference

17 August 2017

page(s)

607-620

1 reference

Amorphous drug nanosuspensions. 1. Inhibition of Ostwald ripening

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.607

Liquid atomizing: nebulizing and other methods of producing aerosols

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.607

The pharmacokinetics of nebulized nanocrystal budesonide suspension in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.607

Why do medical nebulizers differ in their output and particle size characteristics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.607

Rationale for the choice of an aerosol delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.607

Ultrasonic surfactant nebulization with different exciting frequencies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.607

Effect of energy on propylene glycol aerosols using the capillary aerosol generator.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.607

Control of particle size by coagulation of novel condensation aerosols in reservoir chambers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.607

Stability and characterization of perphenazine aerosols generated using the capillary aerosol generator.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.607

Characterization of nebulized buparvaquone nanosuspensions--effect of nebulization technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.607

Pulmonary delivery of insulin with nebulized DL-lactide/glycolide copolymer (PLGA) nanospheres to prolong hypoglycemic effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.607

Surface-modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.607

Antitubercular inhaled therapy: opportunities, progress and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.607

Lymphatic uptake of pulmonary delivered radiolabelled solid lipid nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.607

Sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide)s facilitate the preparation of small negatively charged biodegradable nanospheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.607

Inhalable alginate nanoparticles as antitubercular drug carriers against experimental tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.607

Production and characterization of a budesonide nanosuspension for pulmonary administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.607

Nebulization of biodegradable nanoparticles: impact of nebulizer technology and nanoparticle characteristics on aerosol features

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.607

Nebulization of fluids of different physicochemical properties with air-jet and ultrasonic nebulizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.607

Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.607

Trojan particles: large porous carriers of nanoparticles for drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.607

Formulation and characterization of spray-dried powders containing nanoparticles for aerosol delivery to the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.607

Microencapsulated chitosan nanoparticles for lung protein delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.607

Novel sustained release microspheres for pulmonary drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.607

The role of particle properties in pharmaceutical powder inhalation formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.607

Sub-micrometer particle production by pressurized metered dose inhalers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.607

The efficacy and safety of QVAR (hydrofluoroalkane-beclometasone diproprionate extrafine aerosol) in asthma (part 1): an update of clinical experience in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.607

Size analysis of a pressurized metered dose inhaler-delivered solution formulation by an Aerosizer-LD time-of-flight aerosol particle size spectrometer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.607

Multimodal particle size distributions emitted from HFA-134a solution pressurized metered-dose inhalers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.607

Reverse water-in-fluorocarbon emulsions for use in pressurized metered-dose inhalers containing hydrofluoroalkane propellants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.607

Formation of fluorinated nonionic surfactant microemulsions in hydrofluorocarbon 134a (HFC 134a).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.607

Characterization of fluorocarbon-in-water emulsions with added triglyceride.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.607

Synthesis of Nanoparticles with Novel Technology: High-Gravity Reactive Precipitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.607

Feasibility of preparing nanodrugs by high-gravity reactive precipitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.607

Nanoparticles of poorly water-soluble drugs prepared by supercritical fluid extraction of emulsions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.607

Novel nanoparticles for pulmonary drug administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.607

Novel hydrofluoroalkane suspension formulations for respiratory drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.607

Stability in Colloidal Mixtures Containing Particles with a Large Disparity in Size

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.607

A novel formulation technique for metered dose inhaler (MDI) suspensions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.607

Mucoadhesive nanoparticulate systems for peptide drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.607

Prolonged hypoglycemic effect of insulin-loaded polybutylcyanoacrylate nanoparticles after pulmonary administration to normal rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.607

Lectin-functionalized poly (lactide-co-glycolide) nanoparticles as oral/aerosolized antitubercular drug carriers for treatment of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.607

Experimental study of the deposition of combustion aerosols in the human respiratory tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.607

The optimal particle size for β-adrenergic aerosols in mild asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.607

Investigation of a Novel Condensation Aerosol Generator: Solute and Solvent Effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.607

Analysis of Total Respiratory Deposition of Inhaled Ultrafine Particles in Adult Subjects at Various Breathing Patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.607

21 January 2018

Identifiers

DOI

10.1517/17425247.4.6.607

1 reference

17 August 2017

1 reference